Further studies are needed to define the details of S100A9-dependent MMP-9 induction, as every step in the cascade is a potential therapeutic target to prevent the emergence of tissue-destructive monocytes and macrophages in GPA tissue lesions. The gene discussed is S100A9; the disease is granulomatosis with polyangiitis.